Cardiovascular Medicine 2010 Publications

Journal Articles

  1. Ahimastos AA, Aggarwal A, Savarirayan R, Dart AM, Kingwell BA. A role for plasma transforming growth factor- and matrix metalloproteinases in aortic aneurysm surveillance in Marfan syndrome? Atherosclerosis 2010;209(1):211-4.
  2. Ahrens I, Lip GY, Peter K. New oral anticoagulant drugs in cardiovascular disease. Thromb Haemost 2010;104(1):49-60. Review.
  3. Altmann DR, Korte W, Maeder MT, Fehr T, Haager P, Rickli H, Kleger GR, Rodriguez R, Ammann P. Elevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosis. PLoS One 2010;5(2):e9017.
  4. Ballinger ML, Osman N, Hashimura K, de Haan JB, Jandeleit-Dahm K, Allen T, Tannock LR, Rutledge JC, Little PJ. Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo. J Cell Mol Med 2010;14(6B):1408-18.
  5. Baumert M, Lambert E, Vaddadi G, Sari CI, Esler M, Lambert G, Sanders P, Nalivaiko E. Cardiac repolarization variability in patients with postural tachycardia syndrome during graded head-up tilt. Clin Neurophysiol 2010;122(2):405-9.
  6. Berry PA, Maciewicz RA, Cicuttini FM, Jones MD, Hellawell CJ, Wluka AE. Markers of bone formation and resorption identify subgroups of patients with clinical knee osteoarthritis who have reduced rates of cartilage loss. J Rheumatol 2010;37(6):1252-9.
  7. Berry PA, Maciewicz RA, Wluka AE, Downey-Jones MD, Forbes A, Hellawell CJ, Cicuttini FM. Relationship of serum markers of cartilage metabolism to imaging and clinical outcome measures of knee joint structure. Ann Rheum Dis 2010;69(10):1816-22.
  8. Berry PA, Wluka AE, Davies-Tuck ML, Wang Y, Strauss BJ, Dixon JB, Proietto J, Jones G, Cicuttini FM. The relationship between body composition and structural changes at the knee. Rheumatology 2010;49(12):2362-9.
  9. Bobik A. Circulating microparticles. Markers or participants in carotid artery remodelling? J Hypertens 2010;28(4):673-5. Editorial.
  10. Brennan SL, Pasco JA, Urquhart DM, Oldenburg B, Hanna FS, Wluka AE. The association between urban or rural locality and hip fracture in community-based adults: a systematic review. J Epidemiol Community Health 2010;64(8):656-65. Review.
  11. Burch ML, Ballinger ML, Yang SN, Getachew R, Itman C, Loveland K, Osman N, Little PJ. Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor  type I receptor. J Biol Chem 2010;285(35):26798-805.
  12. Burch ML, Yang SN, Ballinger ML, Getachew R, Osman N, Little PJ. TGF- stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2. Cell Mol Life Sci 2010;67(12):2077-90.
  13. Cameron J, Dart AM. Determinants of raised pulse pressure in women. J Am Coll Cardiol 2010;55(12):1279. Letter.
  14. Cardoso LE, Little PJ, Ballinger ML, Chan CK, Braun KR, Potter-Perigo S, Bornfeldt KE, Kinsella MG, Wight TN. Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein kinase C and extracellular signal-regulated kinase pathways. J Biol Chem 2010;285(10):6987-95.
  15. Chew P, Yuen DY, Stefanovic N, Pete J, Coughlan MT, Jandeleit-Dahm KA, Thomas MC, Rosenfeldt F, Cooper ME, de Haan JB. Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse. Diabetes 2010;59(12):3198-207.
  16. Chu PY, Mariani J, Finch S, McMullen JR, Sadoshima J, Marshall T, Kaye DM. Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am J Pathol 2010;176(4):1735-42.
  17. Davies-Tuck ML, Wluka AE, Forbes A, Wang Y, English DR, Giles GG, Cicuttini F. Smoking is associated with increased cartilage loss and persistence of bone marrow lesions over 2 years in community-based individuals. Rheumatology 2010;48(10):1227-31.
  18. Davies-Tuck ML, Wluka AE, Forbes A, Wang Y, English DR, Giles GG, O'Sullivan R, Cicuttini FM. Development of bone marrow lesions is associated with adverse effects on knee cartilage while resolution is associated with improvement--a potential target for prevention of knee osteoarthritis: a longitudinal study. Arthritis Res Ther 2010;12(1):R10.
  19. Du XJ, Bathgate RA, Samuel CS, Dart AM, Summers RJ. Cardiovascular effects of relaxin: from basic science to clinical therapy. Nat Rev Cardiol 2010;7(1):48-58. Review.
  20. Duffy SJ, Ruygrok P, Juergens CP, Sievert H, Richards M, Blake J, Whitbourn R, Farouque HO, Pertile T, Kaye DM. Removal of contrast media from the coronary sinus attenuates renal injury after coronary angiography and intervention. J Am Coll Cardiol 2010;56(6):525-6.
  21. Esler M. The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol 2010;108(2):227-37. Review.
  22. Esler M. Sympathetic nervous activation in essential hypertension: commonly neglected as a therapeutic target, usually ignored as a drug side effect. Hypertension 2010;55(5):1090-1. Editorial.
  23. Esler M, Lambert E, Schlaich M. Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol 2010;109(6):1996-8; discussion 2016. Review.
  24. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M, for the Symplicity Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomized controlled trial. Lancet 2010;376:1275-1281.
  25. Esler MD, Masuo K. Pharmacological treatments for obesity-related hypertension. Curr Hypertens Rev 2010;6(2):92-9. Review.
  26. Fang L, Du XJ, Gao XM, Dart AM. Activation of peripheral blood mononuclear cells and extracellular matrix and inflammatory gene profile in acute myocardial infarction. Clin Sci 2010;119(4):175-83.
  27. Gao XM, Ming Z, Su Y, Fang L, Kiriazis H, Xu Q, Dart AM, Du XJ. Infarct size and post-infarct inflammation determine the risk of cardiac rupture in mice. Int J Cardiol 2010;143(1):20-8.
  28. Getachew R, Ballinger ML, Burch ML, Little PJ, Osman N. Characterisation of Ki11502 as a potent inhibitor of PDGF  receptor-mediated proteoglycan synthesis in vascular smooth muscle cells. Eur J Pharmacol 2010;626(2-3):186-92.
  29. Getachew R, Ballinger ML, Burch ML, Reid JJ, Khachigian LM, Wight TN, Little PJ, Osman N. PDGF -receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL. Endocrinology 2010;151(9):4356-67.
  30. Gurvitch R, Lefkovits J, Warren RJ, Duffy SJ, Clark DJ, Eccleston D, Yan BP, Reid C, Brennan A, Andrianopoulos N, Ajani AE. Clinical outcomes of drug-eluting stent use in patients with ST-elevation myocardial infarction. Int J Cardiol 2010;143(3):283-8.
  31. Habersberger J, Eisenhardt S, Peter K. C-reactive protein measurement and cardiovascular disease. Lancet 2010;375(9720):1078. Letter.
  32. Hagemeyer CE, Peter K. Targeting the platelet integrin GPIIb/IIIa. Curr Pharm Des 2010;16(37):4119-33. Review.
  33. Kanellakis P, Pomilio G, Agrotis A, Gao X, Du XJ, Curtis D, Bobik A. Darbepoetin-mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor-common -chain heteroreceptor. Br J Pharmacol 2010;160(8):2085-96.
  34. Kaye DM, Byrne MJ, Power JM. Reply to Bridges. Gene Ther 2010;17(4):565-6. Author reply.
  35. Kaye DM, Iles L, Taylor AJ. Myocardial fibrosis in hypertrophic cardiomyopathy. N Engl J Med 2010;363(20):1971. Letter.
  36. Kistler PM, Teh AW. Pulmonary vein tachycardia: is the sinus rhythm P-wave useful. Rev Esp Cardiol 2010;63(2):134-6. Editorial.
  37. Kyaw T, Tay C, Khan A, Dumouchel V, Cao A, To K, Kehry M, Dunn R, Agrotis A, Tipping P, Bobik A, Toh BH. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 2010;185(7):4410-9.
  38. Lambert E, Dawood T, Straznicky N, Sari C, Schlaich M, Esler M, Lambert G. Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J Hypertens 2010;28(3):543-50.
  39. Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N, Chopra R, Wong C, Chatzivlastou K, Head G, Straznicky N, Esler M, Schlaich M, Lambert G. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010;56(3):351-8.
  40. Lambert G, Schlaich M, Lambert E, Dawood T, Esler M. Stress reactivity and its association with increased cardiovascular risk: a role for the sympathetic nervous system? Hypertension 2010;55(6):e20. Letter.
  41. Lancefield T, Clark DJ, Andrianopoulos N, Brennan AL, Reid CM, Johns J, Freeman M, Charter K, Duffy SJ, Ajani AE, Proietto J, Farouque O; MIG (Melbourne Interventional Group) Registry. Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry. JACC Cardiovasc Interv 2010;3(6):660-8.
  42. Lee G, Wu H, Kalman JM, Esmore D, Williams T, Snell G, Kistler PM. Atrial fibrillation following lung transplantation: double but not single lung transplant is associated with long-term freedom from paroxysmal atrial fibrillation. Eur Heart J 2010;31(22):2774-82.
  43. Little PJ, Bhattacharya R, Moreyra AE, Korichneva IL. Zinc and cardiovascular disease. Nutrition 2010;26(11-12):1050-7. Review.
  44. Little PJ, Burch ML, Getachew R, Al-aryahi S, Osman N. Endothelin-1 stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by endothelin receptor transactivation of the transforming growth factor- type I receptor. J Cardiovasc Pharmacol 2010;56(4):360-8.
  45. Maeder MT, Kaye DM. Response to Does the wall stress alone stimulate the natriuretic peptide system? Hypertension 2010;56(6):e176. Author reply.
  46. Maeder MT, Mariani JA, Kaye DM. Hemodynamic determinants of myocardial B-type natriuretic peptide release: relative contributions of systolic and diastolic wall stress. Hypertension 2010;56(4):682-9.
  47. Maeder MT, Thompson BR, Brunner-La Rocca HP, Kaye DM. Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol 2010;56(11):855-63.
  48. Maisa A, Westhorpe C, Elliott J, Jaworowski A, Hearps AC, Dart AM, Hoy J, Crowe SM. Premature onset of cardiovascular disease in HIV-infected individuals: the drugs and the virus. HIV Ther 2010;4 (6):675-692. Review. (IF: 0.7)
  49. Mariani JA, Dawson MA, Avery S, Taylor AJ. Primary cardiac lymphoma. J Am Coll Cardiol 2010;55(13):e23.
  50. Mariani JA, Kaye DM. Delivery of gene and cellular therapies for heart disease. J Cardiovasc Transl Res 2010;3(4):417-26. Review.
  51. Masuo K, Esler MD. Role of sympathetic nerve activity in obesity, hypertension and metabolic syndrome. Curr Hypertens Rev 2010;6(2):83-91. Review.
  52. Masuo K, Esler MD, Lambert GW. Pharmacological treatments for obesity. Immun Endoc Metab Agents Med Chem 2010;10(2):44-9. Review.
  53. Masuo K, Lambert GW, Esler MD. Epinephrine and its role in the development of obesity, hypertension and obesity-related hypertension. Int J Med Biol Front 2010;15(5-6):371-86.
  54. Masuo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP. The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens Res 2010;33(6):521-8. Review.
  55. Masuo K, Rakugi H, Ogihara T, Esler MD, Lambert GW. Cardiovascular and renal complications of Type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. Curr Diabetes Rev 2010;6(2):58-67. Review.
  56. McLellan A, Taylor AJ. Managing diabetics with coronary artery disease. Diabetes Manag J 2010;30:10. Review.
  57. Obeyesekere MN, Chan W, Stub D, Prabhu S, Teo EP, Toogood G, Mariani J, Broughton A, Kistler PM. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population. Pacing Clin Electrophysiol 2010;33(6):696-704.
  58. Peter K. Proteomics unravels platelet function. Blood 2010;115(20):4008-9. Editorial.
  59. Peter K, Lip GY. Changing the scope of preventative and therapeutic approaches in atherothrombosis. Thromb Haemost 2010;103(3):487-8. Editorial.
  60. Peter K, Lip GY. Thrombosis and cardiovascular disease: exciting perspectives in cardiovascular prevention and therapy. Thromb Haemost 2010;103(5):875-6. Editorial.
  61. Pfluger HB, Maeder MT, Lagerche A, Taylor AJ. One- and two-dimensional estimation of right and left ventricular size and function-comparison with cardiac magnetic resonance imaging volumetric analysis. Heart Lung Circ 2010;19(9):541-8.
  62. Rosso R, Kistler PM. Focal atrial tachycardia. Heart 2010;96(3):181-5. Review.
  63. Rosso R, Kistler PM. Sinus rhythm with isolated pulmonary vein fibrillation. Heart 2010;96(4):322.
  64. Rosso R, Sparks PB, Morton JB, Kistler PM, Vohra JK, Halloran K, Medi C, Kalman JM. Vagal paroxysmal atrial fibrillation: prevalence and ablation outcome in patients without structural heart disease. J Cardiovasc Electrophysiol 2010;21(5):489-93.
  65. Schlaich MP, Krum H, Esler MD. New therapeutic approaches to resistant hypertension. Curr Hypertens Rep 2010;12(4):296-302. Review.
  66. Soro-Paavonen A, Zhang WZ, Venardos K, Coughlan MT, Harris E, Tong DC, Brasacchio D, Paavonen K, Chin-Dusting J, Cooper ME, Kaye D, Thomas MC, Forbes JM. Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. J Hypertens 2010;28(4):780-8.
  67. Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376(9756):1903-9.
  68. Taylor AJ, Elsik M, Broughton A, Cherayath J, Leet A, Wong C, Iles L, Butler M, Pfluger H. Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy. Europace 2010;12(5):708-13.
  69. Taylor AJ, Vaddadi G, Pfluger H, Butler M, Bergin P, Leet A, Richardson M, Cherayath J, Iles L, Kaye DM. Diagnostic performance of multisequential cardiac magnetic resonance imaging in acute cardiac allograft rejection. Eur J Heart Fail 2010;12(1):45-51.
  70. Teh AW, Kalman JM, Kistler PM, Lee G, Sutherland F, Morton JB, Vohra JK, Sparks PB. Prevalence of fractionated electrograms in the coronary sinus: comparison between patients with persistent or paroxysmal atrial fibrillation and a control population. Heart Rhythm 2010;7(9):1200-4.
  71. Teh AW, Kalman JM, Medi C, Rosso R, Balasubramaniam R, Lee G, Halloran K, Sparks PB, Morton JB, Vohra JK, Kistler PM. Long-term outcome following successful catheter ablation of atrial tachycardia originating from the pulmonary veins: absence of late atrial fibrillation. J Cardiovasc Electrophysiol 2010;21(7):747-50.
  72. Vaddadi G, Corcoran SJ, Esler M. Management strategies for recurrent vasovagal syncope. Intern Med J 2010;40(8):554-60. Review.
  73. Vaddadi G, Esler MD, Dawood T, Lambert E. Persistence of muscle sympathetic nerve activity during vasovagal syncope. Eur Heart J 2010;31(16):2027-33.
  74. Xu Q, Chakravorty A, Bathgate RA, Dart AM, Du XJ. Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats. Hypertension 2010;55(5):1260-6.
  75. Yang SN, Burch ML, Tannock LR, Evanko S, Osman N, Little PJ. Transforming growth factor- regulation of proteoglycan synthesis in vascular smooth muscle: contribution to lipid binding and accelerated atherosclerosis in diabetes. J Diabetes 2010;2(4):233-42. Review.

I am a PATIENT

i-am-a-patient

Consultation in the Heart Centre is only by referral from a Medical Practitioner.

I am a HEALTH PROFESSIONAL

i-am-a-health-professional

Please follow the link to find further information

Your STORIES

our-stories-home

‘This just doesn’t happen to people like me.’  aged 50...

Support US

the-alfred-foundation

Donate or Volunteer for research study. See how you can help.

Copyright © Alferd Health Victoria 2013 | Login